Omega-3 관련 코르티솔 관련 체중 증가
C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.Omega-3 supplementation may modulate HPA axis response to stress. Small RCTs show reduced cortisol response during mental stress tests. Anti-inflammatory effects may reduce cortisol-driven visceral fat inflammation.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'weightcited.com';
const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dcortisol\u002Dweight';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
결론
Omega-3 supplementation may modulate HPA axis response to stress. Small RCTs show reduced cortisol response during mental stress tests. Anti-inflammatory effects may reduce cortisol-driven visceral fat inflammation.
Key Study Findings
Review
Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of …
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: Patients with acne, HS, or psoriasis
Review
Analytical Review on Nutritional Deficiencies in Vegan Diets: Risks, Prevention, and Optimal Strategies.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
Review
From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel …
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None
vs: None
Outcome: RA risk and disease activity
효과: None
None
대상 집단: Patients with rheumatoid arthritis
Review
Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches.
Dose: None
vs: None
Outcome: Sarcopenia progression and muscle function
효과: None
None
대상 집단: Older adults with sarcopenia (review)
Other
Intestinal anti-inflammatory, histopathologic and anti-oxidative regulatory effects of total alkaloids extract from Linum usitatissimum L. …
Dose: 50, 100, and 200 mg/kg oral
vs: Dexamethasone 2.4 mg/kg; DNBS colitis model vs healthy
Outcome: Colonic inflammation markers (MPO, NO, MDA, CAT, GSH)
효과: None
None
대상 집단: DNBS-induced Crohn's disease BALB/c mouse model
Key Statistics
5
연구
300
참여자
↑
Positive
C
등급
Referenced Papers
Nutrients
2025
9 인용
Journal of the …
2025
7 인용
International journal of …
2025
3 인용
Journal of ethnopharmacology
2025
1 인용
Current obesity reports
2025
Nutrients
2025
Atherosclerosis
2025
European review for …
2023
67 인용
Frontiers in nutrition
2023
17 인용
Nutricion hospitalaria
2021
20 인용
Scientific reports
2020
56 인용
The Journal of …
2020
33 인용
South African medical …
2020
5 인용
American family physician
2018
101 인용
European journal of …
2016
102 인용
International journal of …
2016
56 인용
Clinics in dermatology
2016
19 인용
Prostaglandins & other …
2015
182 인용
Nutrition research (New …
2013
90 인용
Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view.
Systematic Review
World journal of …
2013
56 인용
Alternative medicine review …
2008
The American journal …
2007
310 인용
Digestion
2007
15 인용
International journal of …
2006
85 인용
Alimentary pharmacology & …
2005
50 인용
Journal of Alzheimer's …
2003
161 인용
Journal of psychiatric …
2001
42 인용
Prevention of strokes.
Review
Current atherosclerosis reports
2001
2 인용
Journal of immunology …
1994
119 인용
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 250-500 mg EPA+DHA/day
- antiinflammatory:
- 2,000-4,000 mg/day
- weightmanagement:
- 1,000-3,000 mg EPA+DHA/day
상한량: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| 50, 100, and 200 mg/kg oral | -- | Positive | -- |
| None | -- | Mixed | -- |
| High-dose EPA or DHA | -- | Positive | -- |
권장 복용 시간: With meals containing fat for absorption; may split dose AM/PM
Safety & Side Effects
보고된 부작용
- ⚠ Fishy aftertaste
- ⚠ GI discomfort
- ⚠ Increased bleeding time (at high doses)
- ⚠ Nausea
알려진 상호작용
- ● Blood thinners (may enhance anticoagulant effect at high doses)
- ● Blood pressure medications (additive effect)
- ● Orlistat (reduced absorption)
일일 최대 섭취 허용량: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Omega-3 help with 코르티솔 관련 체중 증가?
Based on 5 studies with 300 participants, there is limited but promising evidence that Omega-3 may support 코르티솔 관련 체중 증가 management. Our evidence grade is C (Some Evidence).
How much Omega-3 should I take for 코르티솔 관련 체중 증가?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3?
Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 and 코르티솔 관련 체중 증가?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.
Related Evidence
관련 다른 성분: 코르티솔 관련 체중 증가
Omega-3 다른 건강 상태에 대한 근거
References
- [1] Riya Gautam Naik et al.. Nutrients. 2025. From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management. doi:10.3390/nu17030470 PubMed
- [2] Anshika Malhotra et al.. J Am Nutr Assoc. 2025. Analytical Review on Nutritional Deficiencies in Vegan Diets: Risks, Prevention, and Optimal Strategies. doi:10.1080/27697061.2025.2461218 PubMed
- [3] Larissa Parreira Araújo et al.. Int J Mol Sci. 2025. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. doi:10.3390/ijms262412147 PubMed
- [4] Mohamed Sofiane Merakeb et al.. J Ethnopharmacol. 2025. Intestinal anti-inflammatory, histopathologic and anti-oxidative regulatory effects of total alkaloids extract from Linum usitatissimum L. (flaxseed) in vivo. doi:10.1016/j.jep.2025.120001 PubMed
- [5] Luigi Barrea et al.. Curr Obes Rep. 2025. Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of Dietetics and Clinical Nutrition (ADI), … doi:10.1007/s13679-025-00630-2 PubMed
- [6] Maria Polyzou et al.. Nutrients. 2025. The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive Review. doi:10.3390/nu17243826 PubMed
- [7] Jacques D Barth. Atherosclerosis. 2025. The omega effect: Harnessing fish oil for health. doi:10.1016/j.atherosclerosis.2025.120461 PubMed
- [8] R Poggioli et al.. Eur Rev Med Pharmacol Sci. 2023. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in … doi:10.26355/eurrev_202308_33310 PubMed
- [9] Angélica Borja-Magno et al.. Front Nutr. 2023. Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid … doi:10.3389/fnut.2023.1156995 PubMed
- [10] Rosa María Martínez García et al.. Nutr Hosp. 2021. [Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. doi:10.20960/nh.03800 PubMed
- [11] Robert Carreras-Torres et al.. Sci Rep. 2020. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. doi:10.1038/s41598-020-76361-2 PubMed
- [12] Julia C Kuszewski et al.. J Nutr. 2020. Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. doi:10.1093/jn/nxaa299 PubMed
- [13] A Jaca et al.. S Afr Med J. 2020. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. doi:10.7196/SAMJ.2020.v110i12.14730 PubMed
- [14] Amy Locke et al.. Am Fam Physician. 2018. Diets for Health: Goals and Guidelines. PubMed
- [15] Tim Y Hou et al.. Eur J Pharmacol. 2016. Omega-3 fatty acids, lipid rafts, and T cell signaling. doi:10.1016/j.ejphar.2015.03.091 PubMed
- [16] K Kaliannan et al.. Int J Obes (Lond). 2016. Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity. doi:10.1038/ijo.2016.27 PubMed
- [17] Meagen McCusker et al.. Clin Dermatol. 2016. Nutrition and skin: Kids are not just little people. doi:10.1016/j.clindermatol.2016.07.004 PubMed
- [18] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed
- [19] Owen J Kelly et al.. Nutr Res. 2013. Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis. doi:10.1016/j.nutres.2013.04.012 PubMed
- [20] Mi-Kyung Sung et al.. World J Gastroenterol. 2013. Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view. doi:10.3748/wjg.v19.i7.994 PubMed
- [21] Parris M Kidd. Altern Med Rev. 2008. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. PubMed
- [22] Devendra K Amre et al.. Am J Gastroenterol. 2007. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. doi:10.1111/j.1572-0241.2007.01411.x PubMed
- [23] Aneta Aleksandra Nielsen et al.. Digestion. 2007. Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin … doi:10.1159/000101560 PubMed
- [24] R M Hackman et al.. Int J Obes (Lond). 2006. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled … doi:10.1038/sj.ijo.0803283 PubMed
- [25] A A Nielsen et al.. Aliment Pharmacol Ther. 2005. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. doi:10.1111/j.1365-2036.2005.02698.x PubMed
- [26] Danielle Laurin et al.. J Alzheimers Dis. 2003. Omega-3 fatty acids and risk of cognitive impairment and dementia. doi:10.3233/jad-2003-5407 PubMed
- [27] R P Brown et al.. J Psychiatr Pract. 2001. Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. doi:10.1097/00131746-200103000-00002 PubMed
- [28] T J Jeerakathil et al.. Curr Atheroscler Rep. 2001. Prevention of strokes. doi:10.1007/s11883-001-0026-7 PubMed
- [29] G Fernandes et al.. J Immunol. 1994. Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W … PubMed
- [30] J Vilaseca et al.. Gut. 1990. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. doi:10.1136/gut.31.5.539 PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.